Basic Pharma
produces tag-free recombinant human serum albumin (rHSA) expressed in Hansenula polymorpha yeast, in collaboration with ARTES Biotechnology (Langenfeld, Germany) — the joint product launched at BIO-Europe (October 30, 2024);…
- Country
- Netherlands
BIO-Europe joint launch with ARTES Biotechnology Oct 30, 2024; Benelux locally-anchored supply
eu
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Recombinant human serum albumin (rHSA) | specialty-fine-chem | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.